证券代码：688350 证券简称：富淼科技 公告编号：2023-035 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 会议召开时间：2023 年 05 月 30 日(星期二) 上午 09:00-10:00 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一） 会议召开时间：2023 年 05 月 30 日 上午 09:00-10:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 ● 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心网络互动 ● 投资者可于 2023 年 05 月 23 日(星期二) 至 0 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 371,485,658.61, representing a decrease of 1.70% compared to the same period last year[5]. - The net profit attributable to shareholders was CNY 13,469,365.96, down 51.64% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 56.26% to CNY 10,452,199.51[10]. - Basic earnings per share were CNY 0.11, a decline of 52.17% compared to the previous year[6]. - Net profit for Q1 2023 was CNY 11,636,531.02, down 58.24% compared to CNY 27,852,502.07 in Q1 2022[21]. - The operating profit for Q1 2023 was ¥17.9 million, a decline of 42.5% from ¥31.1 million in Q1 2022[30]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,455,192,111.40, down 3.41% from the end of the previous year[6]. - As of March 31, 2023, total assets amounted to CNY 2,455,192,111.40, a decrease from CNY 2,541,979,768.60 at the end of 2022, reflecting a decline of approximately 3.4%[16]. - Current assets totaled CNY 1,495,194,987.34, down from CNY 1,617,887,988.20, indicating a decrease of about 7.5%[17]. - Total liabilities as of Q1 2023 amounted to CNY 859,418,529.96, down from CNY 960,596,929.18 in the previous year[19]. - The total liabilities decreased to 742,993,125.08 RMB from 805,645,658.27 RMB, indicating a reduction of approximately 7.77%[27]. Cash Flow - The net cash flow from operating activities was CNY -46,025,592.56, indicating a significant cash outflow[5]. - The company's cash flow from operating activities showed a significant increase, indicating improved operational efficiency despite a decline in net profit[24]. - Cash inflow from operating activities totaled CNY 333,361,900.53, compared to CNY 276,780,086.46 in Q1 2022, reflecting a growth of 20.41%[24]. - The cash flow from operating activities showed a net outflow of ¥28.2 million in Q1 2023, compared to a net inflow of ¥10.8 million in Q1 2022[33]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,525[12]. - The company reported a total of 10,779,977 shares held by Beijing Ruishi Bang Fine Chemical Technology Co., Ltd., making it the largest unrestricted shareholder[14]. - The second-largest shareholder, Jiang Feng, holds 2,915,595 shares, representing 2.39% of the total shares[14]. Research and Development - Research and development expenses totaled CNY 15,669,388.94, accounting for 4.22% of operating revenue, a decrease of 0.2 percentage points[6]. - Research and development expenses decreased to ¥8.7 million in Q1 2023, down 28.5% from ¥12.2 million in Q1 2022[29]. Investment Activities - The company has ongoing investments in new technologies and products, although specific details were not disclosed in the report[15]. - Cash inflow from investment activities was 299,683,357.42 RMB, compared to 281,446,119.03 RMB in the previous year, marking an increase of 6.4%[25]. - Cash outflow from investment activities totaled 426,745,379.32 RMB, up from 316,501,365.24 RMB, representing a significant increase of 34.8%[25]. - The company raised 23,317,380.00 RMB from new investments, compared to no new investments in the previous year[25]. Financial Expenses - The company reported a financial expense of CNY 1,853,988.48 in Q1 2023, compared to a financial income of CNY 135,412.73 in Q1 2022[20]. - The company reported a significant increase in financial expenses, with interest expenses rising to ¥2.6 million in Q1 2023 from ¥0.1 million in Q1 2022[29].

Dividend and Financial Performance - The company plans to distribute a cash dividend of 2.48 RMB per 10 shares, totaling approximately 30,052,349.10 RMB (including tax) based on a total share capital of 121,178,827 shares after accounting for repurchased shares[6]. - The total amount for cash dividends and the total funds used for share repurchase via centralized bidding is 94,569,928.46 RMB, which accounts for 73.76% of the net profit attributable to the parent company's shareholders[7]. - The company has not proposed any stock dividends or capital reserve transfers to increase share capital for the year 2022[7]. - The company's operating revenue for 2022 was ¥1,696,761,789.38, representing a year-on-year increase of 16.83% due to increased sales of water-soluble polymers and the consolidation of revenue from the newly acquired Suzhou Jingchang Technology Development Co., Ltd.[26]. - The net profit attributable to shareholders of the listed company reached ¥128,212,303.90, a growth of 19.54% compared to the previous year, with the net profit after deducting non-recurring gains and losses at ¥105,140,782.37, up 17.63% year-on-year[26][27]. - The net cash flow from operating activities was ¥140,111,947.11, an increase of 45.88% year-on-year, primarily due to improved management of working capital and a reduction in accounts receivable[27]. - The net assets attributable to shareholders of the listed company at the end of 2022 were ¥1,497,494,478.42, a 7.4% increase from the end of the previous year, driven by profits and dividends[27]. - Total assets increased by 37.56% year-on-year to ¥2,541,979,768.60, mainly due to the acquisition of Suzhou Jingchang Technology Development Co., Ltd. and funds raised from issuing convertible bonds[27]. - Basic and diluted earnings per share for 2022 were both ¥1.04, reflecting a year-on-year increase of 15.56%[25]. Market Expansion and Growth Strategies - Jiangsu Feymer Technology Co., Ltd. reported significant growth in revenue, achieving a total of 1.2 billion RMB in 2022, representing a year-over-year increase of 15%[16]. - The company expanded its user base, with an increase of 20% in active users, reaching 500,000 by the end of 2022[16]. - Future outlook indicates a projected revenue growth of 10% for 2023, driven by new product launches and market expansion strategies[16]. - Market expansion efforts include entering Southeast Asian markets, targeting a 5% market share by 2025[16]. - The company has completed a strategic acquisition of a local competitor, enhancing its production capacity by 30%[16]. - Jiangsu Feymer plans to increase its workforce by 10% in 2023 to support its growth initiatives[16]. - The company aims to enhance operational efficiency, targeting a 10% reduction in energy consumption across its facilities by 2024[16]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[26]. Research and Development Initiatives - The company is investing in R&D for new water treatment membrane products, with an allocated budget of 100 million RMB for 2023[16]. - The company added 50 new authorized patents during the reporting period, including 26 invention patents and 24 utility model patents, bringing the total to 210 authorized patents[39]. - Research and development expenses accounted for 4.73% of operating revenue, an increase of 0.34 percentage points compared to the previous year[26]. - The company achieved a conversion rate and selectivity of over 99.9% in the production of acrylamide, resulting in high product yield and purity[76]. - The company has developed a water-dispersible polyacrylamide production technology with high effective ingredient content and fast dissolution speed, suitable for various applications[77]. - The company is focusing on the development of functional monomers and water-soluble polymers, with 21 core technologies established across various applications[75]. - The company has developed a complete industrial chain from functional monomers to water-soluble polymers and water treatment membranes, with over 100 specifications of products widely used in various markets[96]. Corporate Governance and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[10]. - The company has not violated any decision-making procedures for providing guarantees[10]. - The company has received a standard unqualified audit report from Zhonghui Certified Public Accountants[5]. - The company has not reported any special arrangements for corporate governance[8]. - The company confirmed that all board members attended the board meeting[4]. - The company has committed to maintaining transparency in its financial reporting and governance practices[166]. - The company is focused on enhancing its corporate governance structure in line with regulatory requirements[166]. - The company has established a closed-loop system connecting customer needs, technology development, product production, and application to strengthen product competitiveness[98]. Financial Management and Cost Control - The total cost for the reporting period was CNY 1,159,903,570.76, representing a 21.54% increase compared to CNY 954,343,073.40 in the previous year[120]. - Direct materials accounted for over 80% of the company's main business costs, with key raw materials being closely tied to fluctuations in international oil prices[105]. - The gross profit margin decreased by 1.34% due to rising costs of key raw materials and increased sales expenses from the acquisition[114]. - The company has implemented a comprehensive financial management platform to address issues such as high idle fund rates and account reconciliation difficulties[45]. - The company has established subsidiaries to expand into water treatment membrane products, but market share remains low and development is still in the early stages[103]. Safety and Environmental Compliance - The company maintained a zero recordable injury rate (TRIR) for two consecutive years, indicating strong safety performance[41]. - The company is focused on green technology and aims to support the high-quality development of downstream customers in water-based industries[36]. - The company is subject to stricter environmental regulations, which could lead to production limitations or penalties if compliance is not met[102]. - The company has implemented a dual prevention mechanism for safety risk management, enhancing safety awareness and reducing incidents[159]. Talent Development and Management - During the reporting period, the company introduced 3 PhDs and 6 Master's degree holders to strengthen its talent pool and enhance management capabilities[46]. - The total number of R&D personnel increased to 114, representing 13.99% of the company's total workforce, up from 105 and 13.61% in the previous period[93]. - The company has a multi-level talent system to enhance its competitive edge, including senior management with experience in Fortune 500 companies[97]. - The company is committed to talent development and optimizing its incentive system to improve organizational effectiveness and internal collaboration[158]. Strategic Partnerships and Acquisitions - The company completed a strategic acquisition of a competitor for $300 million, enhancing its product portfolio[181]. - The company is exploring potential acquisitions to further enhance its product portfolio, with a budget of 300 million allocated for this purpose[182]. - The company acquired 100% of Suzhou Jingchang Technology Development Co., Ltd. for CNY 130,510,000, which will impact the consolidated financial statements starting from August 1, 2022[122]. - The company has established strategic partnerships with three key suppliers to secure raw materials, which is expected to stabilize production costs in 2023[187]. Shareholder Engagement and Meetings - The company held its annual general meeting on April 7, 2022, where several key resolutions were passed, including the approval of the 2021 annual financial report[166]. - The resolutions passed during the shareholder meetings were all approved without any being rejected, ensuring compliance with the Company Law and Articles of Association[169]. - The attendance at shareholder meetings was consistent, with most directors attending all three meetings[198]. - The company has maintained a high level of engagement from its board members throughout the year[198].

2022 年第三季度报告 证券代码：688350 证券简称：富淼科技 江苏富淼科技股份有限公司 2022 年第三季度报告 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 443,132,471.75 | 20.05 | 1,236,567,994.71 | 19.29 | | 归属于上市公司股东的 净利润 | 26,570,233.84 | -4.95 | 88,841,152.46 | -1.36 | | 归属于上市公司股东的 扣除非经常性损益的净 | 23,164,942.97 | 0.22 | 78,209,605.32 | 8.49 | | 利润 | | | | | 1 / 19 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性 ...

Financial Performance - The company reported a total revenue of RMB 500 million for the first half of 2022, representing a year-on-year increase of 15%[1]. - The company has set a revenue guidance of RMB 1.2 billion for the full year 2022, reflecting an expected growth of 10%[1]. - The company's operating revenue for the first half of 2022 was ¥793,435,522.96, representing an increase of 18.87% compared to ¥667,460,031.82 in the same period last year[21]. - The net profit attributable to shareholders for the first half of 2022 was ¥62,270,918.62, a slight increase of 0.26% from ¥62,109,220.49 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥55,044,662.35, which is a 12.39% increase from ¥48,974,432.98 in the same period last year[21]. - The net cash flow from operating activities decreased by 32.33% to ¥35,989,056.35 from ¥53,185,810.74 in the previous year[21]. - The total assets at the end of the reporting period were ¥1,818,135,170.38, down 1.61% from ¥1,847,893,883.47 at the end of the previous year[21]. - The net assets attributable to shareholders decreased by 1.55% to ¥1,372,695,209.94 from ¥1,394,285,522.09 at the end of the previous year[21]. - Basic earnings per share for the first half of 2022 were ¥0.51, a decrease of 3.77% compared to ¥0.53 in the same period last year[22]. Market Expansion and Strategy - User data indicates a growth in active users by 20% compared to the same period last year, reaching 1.2 million active users[1]. - New product launches contributed to 30% of total revenue, with significant demand for the latest technology solutions[1]. - The company is expanding its market presence in Southeast Asia, targeting a 25% increase in market share by the end of 2023[1]. - The company is focusing on expanding its product offerings in high-performance and new products to meet the evolving demands of downstream industries[30]. - The company aims to increase its market presence in the oil and gas sector, particularly in drilling and fracturing agents, despite currently having a low market share[35]. Research and Development - Research and development expenses increased by 18%, totaling RMB 80 million, focusing on innovative technologies[1]. - The company's R&D expenditure accounted for 4.58% of operating revenue, reflecting a slight increase of 0.05 percentage points[23]. - The company achieved a total R&D investment of ¥36,324,980.24, representing a 20.12% increase compared to ¥30,239,506.16 in the previous year[57]. - The company holds a total of 151 authorized patents, including 58 invention patents, reflecting ongoing innovation in water-soluble polymer manufacturing and water treatment membrane technology[55]. - The company has 15 ongoing R&D projects, demonstrating a commitment to advancing its core technologies[55]. Operational Efficiency and Cost Management - The company has implemented new strategies to enhance operational efficiency, aiming for a 5% reduction in operational costs by the end of 2022[1]. - The production model combines monthly planning for regular products with customized production for large projects, minimizing inventory costs while ensuring timely delivery[45]. - The company is focusing on enhancing product quality and reducing costs through ongoing research and development efforts across various projects[58]. Risks and Challenges - The management highlighted potential risks including market volatility and supply chain disruptions, which could impact future performance[1]. - The company faces risks related to core technology personnel turnover and the need for continuous R&D investment to maintain competitiveness[81]. - The company faced risks from rising raw material prices, particularly due to geopolitical factors affecting international oil prices[86]. - The company is experiencing increased competition in the functional monomer sector, with pressure from both domestic and international competitors[87]. Environmental and Compliance - The company has implemented a zero wastewater discharge upgrade project, achieving water reuse through its sewage treatment station[112]. - The company’s main pollutants emissions comply with national or local regulations[112]. - The company has established an emergency response plan for environmental incidents, which has been filed with the Zhangjiagang Environmental Emergency Response Center[118]. - The company optimized its thermal power production unit, reducing raw coal consumption by approximately 1,000 tons and CO2 emissions by 2,000 tons in the first half of the year[120]. Shareholder and Corporate Governance - The company has no plans for major acquisitions in the near term, prioritizing organic growth strategies[1]. - The company guarantees not to misuse its position to harm the interests of the company or its shareholders through related party transactions[132]. - The company commits to maintaining transparency and accountability in its financial reporting and investor communications[162]. - The company will ensure compliance with all legal and regulatory requirements regarding shareholder equity changes and will disclose any stock reduction plans[148].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 377,916,101.28, representing a year-over-year increase of 20.62%[5] - The net profit attributable to shareholders decreased by 18.72% to CNY 27,852,502.07[5] - The net profit after deducting non-recurring gains and losses was CNY 23,896,732.20, down by 11.89% compared to the same period last year[5] - Basic earnings per share were CNY 0.23, a decrease of 25.81% year-over-year[6] - Net profit for Q1 2022 was CNY 27,852,502.07, compared to CNY 34,264,351.60 in Q1 2021, reflecting a decrease of approximately 18.6%[24] - Earnings per share for Q1 2022 were CNY 0.23, down from CNY 0.31 in Q1 2021, a decline of about 25.8%[24] - The company's net profit for Q1 2022 was CNY 28,186,193.36, a decrease of 9.1% compared to CNY 31,331,348.46 in Q1 2021[35] - The total profit for Q1 2022 was CNY 31,210,587.28, down from CNY 35,749,919.80 in Q1 2021, representing a decline of 12.7%[35] Cash Flow - The net cash flow from operating activities increased significantly by 355.46% to CNY 16,094,073.39[5] - Cash flow from operating activities increased to CNY 10,830,285.70 in Q1 2022, compared to CNY 8,904,170.77 in Q1 2021, representing a growth of 21.6%[37] - Net cash flow from investing activities for Q1 2022 was negative CNY 35,055,246.21, compared to negative CNY 258,784,789.42 in Q1 2021, indicating an improvement[29] - The company reported a net cash outflow from investing activities of CNY 14,647,912.65 in Q1 2022, an improvement from a net outflow of CNY 257,369,016.34 in Q1 2021[38] - The company reported a net cash outflow from financing activities of negative CNY 4,246,977.85 in Q1 2022, a decrease from a net inflow of CNY 386,598,073.65 in Q1 2021[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,841,127,365.77, a decrease of 0.37% from the end of the previous year[6] - The total assets as of Q1 2022 were CNY 1,841,127,365.77, slightly down from CNY 1,847,893,883.47 at the end of the previous period[19] - Total current assets as of March 31, 2022, amounted to ¥1,186,132,798.24, a decrease from ¥1,205,084,185.89 as of December 31, 2021, reflecting a decline of approximately 1.5%[17] - Total liabilities for Q1 2022 were CNY 429,583,332.93, a decrease from CNY 453,608,361.38 in the previous period, showing a reduction of approximately 5.3%[19] - Total liabilities decreased to CNY 357,795,727.93 as of March 31, 2022, from CNY 383,077,399.64 as of December 31, 2021[33] Research and Development - Research and development expenses totaled CNY 16,694,187.09, accounting for 4.42% of operating revenue, an increase of 0.23 percentage points[6] - Research and development expenses for Q1 2022 were CNY 16,694,187.09, up from CNY 13,112,243.46 in Q1 2021, reflecting an increase of approximately 27.5%[23] - Research and development expenses rose significantly to CNY 12,192,323.91 in Q1 2022, compared to CNY 8,413,932.73 in Q1 2021, marking an increase of 44.5%[35] Shareholder Information - The company reported a total of 10,860,977 shares held by Beijing Ruishi Bang Fine Chemical Technology Co., Ltd., representing 8.89% of total shares[14] - The top ten shareholders collectively hold significant stakes, with the largest shareholder owning 10,860,977 shares, indicating a concentrated ownership structure[14] Other Information - The company has not disclosed any new product developments or technological advancements during this reporting period[15] - There are no significant mergers or acquisitions reported in the current quarter[15] - The company has not provided specific future guidance or performance outlook for the upcoming quarters[15] - No significant changes in the management or operational strategies were noted in the report[15]

Financial Performance - The company reported a total distributable profit of RMB 336,177,878.06 as of December 31, 2021, with a proposed cash dividend of RMB 4.10 per 10 shares, amounting to a total of RMB 50,081,500.00, which represents 46.69% of the net profit attributable to shareholders [5]. - The company's operating revenue for 2021 was CNY 1,452,319,318.41, an increase of 27.98% compared to the previous year [22]. - The net profit attributable to shareholders was CNY 107,253,147.54, reflecting a growth of 2.23% year-on-year [24]. - The net cash flow from operating activities was CNY 96,049,135.99, down 41.99% year-on-year due to increased receivables and inventory costs [25]. - The total assets at the end of 2021 were CNY 1,847,893,883.47, an increase of 41.02% from the previous year [25]. - The net assets attributable to shareholders reached CNY 1,394,285,522.09, up 43.71% year-on-year [25]. - The basic earnings per share for 2021 were CNY 0.90, a decrease of 21.74% compared to 2020 [23]. - The company's total revenue for the reporting period was ¥1,438,371,917.94, representing a year-on-year increase of 27.97% [114]. - The company reported a significant increase in revenue for 2021, reaching a total of 1.5 billion RMB, representing a 20% growth year-over-year [168]. Dividend Policy - The total share capital of the company is 122,150,000 shares, and the cash dividend distribution is subject to approval at the shareholders' meeting [6]. - The company does not plan to issue bonus shares or convert capital reserves into share capital, focusing on cash dividends instead [5]. - The company's board of directors has approved the profit distribution plan, pending shareholder approval, reflecting a commitment to returning value to shareholders [6]. - The company maintains a cash dividend policy that ensures at least 10% of the distributable profits are allocated as cash dividends in profitable years [196]. - The company has a policy that mandates cash dividends to be at least 80% of the distributable profits if in a mature stage without major capital expenditures [197]. Research and Development - Research and development expenses accounted for 4.39% of operating revenue, slightly up from 4.28% in 2020 [23]. - The company is investing $50 million in R&D for new technologies aimed at enhancing product efficiency [167]. - The total R&D expenditure for the year was ¥63,795,520.60, an increase of 31.30% compared to the previous year, with R&D expenditure as a percentage of operating income rising to 4.39% [80]. - The company has developed over 100 specifications of functional monomers and four categories of water-soluble polymers, enhancing its core industry chain [93]. - The company is focusing on developing high-performance paper strengthening agents to meet the increasing demands of the paper industry, where recycled paper fibers account for 70% of raw materials [63]. Market Expansion and Strategy - The company is exploring acquisition opportunities to enhance its product portfolio, targeting firms with revenues of $100 million to $500 million [167]. - Market expansion efforts have led to a 20% increase in market share in the Asia-Pacific region [167]. - The company plans to enter two new international markets by Q2 2024, aiming for a revenue contribution of $100 million [1]. - The company is actively constructing a project for an annual production capacity of 33,000 tons of water treatment and industrial water specialty chemicals, with trial production expected in Q2 2022 [42]. - The company aims to enhance its competitive edge by providing tailored solutions and maintaining cost competitiveness through large-scale manufacturing of core products [60]. Corporate Governance - The company has established a sound corporate governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and management team, complying with relevant laws and regulations [152]. - The company actively engages with shareholders and investors through various communication channels, ensuring their rights are protected [152]. - The company has implemented measures to strengthen the management of insider information and ensure compliance with disclosure obligations [152]. - The company has not encountered any significant issues regarding independence from its controlling shareholders or related party competition [152]. - The company held its annual general meeting in April 2021, where all proposed resolutions were approved without any rejections [157]. Operational Efficiency - The company has reduced operational costs by 5%, resulting in improved profit margins [167]. - The company achieved a significant improvement in product yield and stability by transitioning to a continuous production method for quaternary ammonium salts, resulting in reduced impurities and energy consumption [73]. - The company is focusing on market expansion in the fields of membrane technology and wastewater treatment, with a strong competitive edge in the aluminum ore processing sector [85]. - The company has established a CRM system to digitize the entire sales process, supporting business expansion efforts [40]. - The company plans to implement a comprehensive digital development strategy to improve operational efficiency through various information management systems [147]. Risks and Challenges - The company has outlined various operational risks and corresponding mitigation strategies in the report, emphasizing the importance of risk management [4]. - The company faces risks related to core technology personnel turnover and potential R&D project failures, which could adversely affect operational performance [98]. - The company is exposed to foreign exchange risks, particularly from fluctuations in the RMB exchange rate, which could adversely affect profits as export business scales up [100]. - The company is classified as a key management enterprise under pollutant discharge permit regulations, facing increased scrutiny and potential penalties for environmental compliance [98]. - The company faces risks from macroeconomic fluctuations and extreme weather impacting supply chains [107]. Employee and Talent Management - The company has implemented a comprehensive talent training system, with 27 participants in the "Lingyun Plan" for senior management and 34 in the "Wutong Plan" for middle management [194]. - The total number of employees in the parent company and major subsidiaries is 778, with 566 in the parent company and 212 in subsidiaries [191]. - The company has a total of 48 employees with a master's degree or above, and 164 with a bachelor's degree [192]. - The company has established a performance evaluation system to enhance employee motivation and creativity, with a focus on salary, performance bonuses, and year-end bonuses for senior management [200]. - The company has initiated a new employee stock ownership plan, which will allocate 2.5% of shares to employees, enhancing retention and motivation [171].

2021 年第三季度报告 证券代码：688350 证券简称：富淼科技 江苏富淼科技股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 上年同期增 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | | 年初至报告期末 | | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 369,126,938.76 | 21.16 | 1,036,586, ...

Financial Performance - The company reported a total distributable profit of RMB 285,178,578.55 as of December 31, 2020[5]. - The cash dividend represents 47.74% of the net profit attributable to the parent company's shareholders for the year[5]. - The company's operating revenue for 2020 was approximately CNY 1.135 billion, a slight increase of 0.39% compared to CNY 1.130 billion in 2019[21]. - The net profit attributable to shareholders for 2020 was CNY 104.91 million, representing a growth of 23.07% from CNY 85.25 million in 2019[21]. - The net profit after deducting non-recurring gains and losses was CNY 96.01 million, up 16.57% from CNY 82.36 million in the previous year[21]. - The cash flow from operating activities for 2020 was CNY 165.57 million, a decrease of 15.95% compared to CNY 196.99 million in 2019[21]. - The total assets at the end of 2020 were CNY 1.310 billion, an increase of 2.73% from CNY 1.276 billion at the end of 2019[22]. - The net assets attributable to shareholders at the end of 2020 were CNY 970.19 million, reflecting a growth of 7.17% from CNY 905.28 million at the end of 2019[22]. - The basic and diluted earnings per share were CNY 1.15, reflecting a growth of 23.66% year-on-year[25]. - The company's net cash flow from operating activities was CNY 165,574,725.46, which is 157.85% of the net profit for the period[24]. Dividend Policy - A cash dividend of RMB 4.10 per 10 shares (including tax) is proposed, totaling RMB 50,081,500 (including tax) based on a total share capital of 122,150,000 shares[5]. - The cash dividend distribution policy stipulates that at least 10% of the distributable profit should be distributed in cash if the company is profitable[142]. - The company aims to maintain a stable and continuous profit distribution policy to ensure reasonable returns to investors[142]. - The cash dividend for 2020 is proposed to be RMB 4.10 per 10 shares[146]. - The company has not proposed any stock dividends or capital reserve transfers for the year 2020[146]. - The company completed a cash dividend distribution of RMB 40 million for the year 2019[145]. Research and Development - Research and development expenses accounted for 4.28% of operating revenue, a slight decrease from 4.46% in the previous year[23]. - The company has set up multiple R&D centers focusing on polymer and membrane technology, ensuring alignment with market needs and national policies[42]. - The company adheres to a research and development strategy focused on "independent research and development as the mainstay, supported by external collaboration," establishing partnerships with several universities for technology development[43]. - The total R&D investment for the year was approximately ¥48.59 million, representing 4.28% of total revenue, a slight decrease from 4.46% in the previous year[67]. - The company holds a total of 100 authorized patents, including 32 invention patents, reflecting continuous innovation and enhancement of its technology portfolio[65]. Market Position and Strategy - The company focuses on hydrophilic functional polymer products and technologies, serving water-based industries such as water treatment and oil extraction, aiming for green development and ecological protection[35]. - The company is positioned in a growing industry, with the national goal of reducing carbon emissions and promoting ecological civilization, which is expected to drive the growth of the water-soluble polymer and water treatment membrane sectors[45]. - The company actively participates in the establishment of industry standards, having contributed to 12 national/industry standards, with several already in implementation[52]. - The company holds a significant market share in functional monomers, particularly in DMDAAC, and has improved its market position in the papermaking sector in 2020[51]. - The company aims to enhance R&D investment to upgrade its technology center and improve product development capabilities[134]. Operational Efficiency - The company implemented proactive measures during the COVID-19 pandemic to ensure production continuity and market expansion, enhancing operational efficiency[24]. - The company has established a complete industrial chain from key raw materials to core products, enhancing its competitive edge in new product and technology development[76]. - The company is focusing on lean management projects to improve organizational efficiency and long-term competitiveness[82]. - The company achieved significant advancements in water treatment membrane technology, including the development of high-performance PVDF hollow fiber membrane materials[64]. - The company has made significant progress in optimizing production processes based on customer feedback, enhancing product performance and quality[81]. Risks and Challenges - The company faces risks from intensified market competition, particularly in the functional monomer sector, where it competes with multinational chemical companies[98]. - The ongoing impact of the COVID-19 pandemic has created uncertainties that may affect business expansion and accounts receivable recovery[102]. - The company's main raw materials, including acrylonitrile and chloroprene, constitute over 80% of its main business costs, with prices closely linked to crude oil fluctuations, which may impact operating performance[96]. - The company's net accounts receivable at the end of the reporting period was approximately 246.44 million yuan, representing 34.08% of current assets, indicating potential risks related to cash flow and bad debts[100]. - The company is exposed to risks from changes in industry regulations, particularly concerning safety and environmental standards, which could affect normal operations[95]. Future Outlook - The company provided a positive outlook for 2021, projecting a revenue growth of 10% to 12%[152]. - New product launches are expected to contribute an additional $50 million in revenue in 2021[153]. - Market expansion plans include entering three new international markets by Q3 2021[155]. - The company aims to improve operational efficiency, targeting a 5% reduction in costs by the end of 2021[150]. - The company plans to strengthen brand building and market development to increase customer satisfaction and market share[135].

Financial Performance - The company reported a total revenue of RMB 500 million for the first half of 2021, representing a year-on-year increase of 20%[1]. - The company's operating revenue for the first half of 2021 was ¥667,460,031.82, representing a 29.70% increase compared to ¥514,612,992.29 in the same period last year, primarily due to enhanced market development and brand influence[20]. - The net profit attributable to shareholders for the first half of 2021 was ¥62,109,220.49, a 7.90% increase from ¥57,564,233.97 in the previous year[20]. - The net cash flow from operating activities decreased by 49.05% to ¥53,185,810.74 from ¥104,380,331.32 in the same period last year[20]. - The company's total assets increased by 29.37% to ¥1,695,181,381.11 from ¥1,310,341,841.89 at the end of the previous year[21]. - The net assets attributable to shareholders rose by 39.06% to ¥1,349,141,133.65 from ¥970,190,247.08 at the end of the previous year[21]. - Basic earnings per share for the first half of 2021 were ¥0.53, down 15.87% from ¥0.63 in the same period last year[22]. - The net profit excluding non-recurring gains and losses was ¥48,974,432.98, a decrease of 8.19% year-on-year[23]. - The company received government subsidies amounting to ¥12,264,210.77, contributing positively to the financial results[26]. Market Strategy and Expansion - The company expects a revenue growth forecast of 25% for the second half of 2021, driven by new product launches and market expansion strategies[1]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2022[1]. - The company continues to focus on expanding its market presence and enhancing brand recognition as part of its growth strategy[20]. - The company is positioned in the water-soluble polymer and water treatment membrane market, which is expected to grow due to increasing environmental regulations and demand for resource recycling[30]. - The national policy aims for a 25% reuse rate of reclaimed water in major cities by 2025, with specific targets for different regions, which supports the company’s market potential[36]. Research and Development - Research and development expenses increased by 30% to RMB 50 million, focusing on new technologies in water treatment solutions[1]. - The research and development expenditure accounted for 4.53% of operating revenue, slightly increasing from 4.51% in the previous year[22]. - The company has multiple R&D centers focusing on polymer and membrane technology, emphasizing independent research and external collaboration[47]. - The company has undertaken several national and provincial research projects, including the "Liquid Water-Soluble Polymer Concentrate (CAPC) Project" and "Oil-in-Water Polyacrylamide Emulsion Technology Development"[48]. - The company has developed a functional monomer manufacturing technology with a conversion rate and selectivity of over 99.9% for acrylamide production, achieving high product yield and purity[50]. - The company has developed a new organic sludge dewatering technology that utilizes high-charge, high-channel organic water-soluble polymer dewatering agents[53]. - The company is currently working on 14 R&D projects, focusing on water-soluble polymer manufacturing and water treatment membrane technology[54]. Operational Efficiency and Cost Management - The company has implemented new strategies to enhance operational efficiency, aiming for a 15% reduction in production costs by the end of 2021[1]. - The procurement model combines market-based and strategic purchasing, maintaining long-term agreements with quality suppliers to stabilize supply and control costs[44]. - The production model for functional monomers and water-soluble polymers is based on monthly planning, ensuring safety stock while meeting customer orders[44]. - The company is committed to continuous improvement in production efficiency and safety through lean management practices[75]. Environmental Compliance and Sustainability - The company has implemented effective monitoring and treatment of pollution sources, ensuring compliance with national and local emission standards[110]. - The company has committed to zero wastewater discharge through upgraded treatment projects, achieving water reuse[109]. - The company is participating in the national carbon market trading, with a focus on reducing carbon emissions through various measures[115]. - The "All-in-One Thermal Power Cloud" project is expected to reduce carbon dioxide emissions by 6,500 tons annually by improving production efficiency and reducing coal consumption[115]. Risks and Challenges - The company has identified potential risks related to supply chain disruptions and has outlined mitigation strategies in the report[1]. - The company faces risks related to technological updates, core personnel retention, and potential R&D failures that could impact operational performance[79]. - The competitive landscape in the functional monomer and water treatment sectors is intensifying, with significant pressure from established multinational companies[86]. - The ongoing global pandemic and extreme weather events pose uncertainties that could disrupt supply chains and affect business operations[88]. Shareholder Commitments and Governance - The company commits to not transferring or entrusting the management of its pre-IPO shares for 36 months from the date of listing[125]. - The company will publicly disclose any failure to fulfill commitments and apologize to shareholders if it causes losses in securities trading[126]. - The company will ensure compliance with all legal and regulatory requirements regarding shareholder obligations and shareholding changes[151]. - The company will conduct profit distributions annually, with the possibility of mid-term dividends based on profitability and funding needs[172].